Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze HII stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate HII investment potential.

What is HII stock price today?

Get real-time HII stock price, historical data, and price charts on Financhill. Track HII performance with our advanced analysis tools.

Is HII a good investment?

Evaluate HII investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy HII stock?

To buy HII stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of HII?

View detailed market capitalization data and company valuation metrics for HII on our comprehensive analysis page.

What is the P/E ratio of HII?

Use our fundamental analysis tools to view HII P/E ratio and compare valuation metrics with industry peers.

What are HII earnings?

View HII earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Huntington Ingalls Industries, Inc. 10K Form

Buy

HII
Huntington Ingalls Industries, Inc.

Last Price:

$396.63

Seasonality Move:

0.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HII News And Ratings

See the #1 stock for the next 7 days that we like better than HII

HII Financial Statistics

Sales & Book Value

Annual Sales:	$12.5B
Cash Flow:	$516M
Price / Cash Flow:	19.83
Annual Sales:	$129.28
Price / Book:	3.09

Profitability

EPS (TTM):	15.36500
Net Income (TTM):	$605M
Gross Margin:	$1.6B
Return on Equity:	12.41%
Return on Assets:	4.84%

Huntington Ingalls Industries, Inc. Earnings Forecast

Key Huntington Ingalls Industries, Inc. Financial Ratios

The Gross Profit Margin over the past 16 years for HII is 12.70%.
The Selling, General & Administrative Expenses for HII have been equal to 7.83% of Gross Profit Margin.
The Research & Development expenses have been 0.21% of Revenue.
The Interest Expense is 17.36% of Operating Income.
The Net Earning history of HII is 4.85% of Total Revenues.
Per Share Earnings over the last 16 years have been positive in 10 years.

Huntington Ingalls Industries, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Aerospace & Defense
Sector:	Industrials
Current Symbol:	HII
CUSIP:	446413
Website:	hii.com

Debt

Debt-to-Equity Ratio:	0.59
Current Ratio:	1.13
Quick Ratio:	0.94

Price-to-Earnings

Trailing P/E Ratio:	25.98
Forward P/E Ratio:	19.65

HII Technical Analysis vs Fundamental Analysis

Buy

Huntington Ingalls Industries, Inc. (HII) is a Buy

Is Huntington Ingalls Industries, Inc. a Buy or a Sell?

Huntington Ingalls Industries, Inc. stock is rated a Buy

The current Huntington Ingalls Industries, Inc. [HII] share price is $396.62. The Score for HII is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.